TrianglePUBLICATIONS · 23281268
Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2013 Jul
- First author
- Skapek SX
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Skapek SX
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Hill DA
- type
- Author
- name
- Henry D
- type
- Author
- name
- Spunt SL
- type
- Author
- name
- Meyer W
- type
- Author
- name
- Kao S
- type
- Author
- name
- Hoffer FA
- type
- Author
- name
- Grier HE
- type
- Author
- name
- Hawkins DS
- type
- Author
- name
- Raney RB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Skapek SX
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Hill DA
- type
- Author
- name
- Henry D
- type
- Author
- name
- Spunt SL
- type
- Author
- name
- Meyer W
- type
- Author
- name
- Kao S
- type
- Author
- name
- Hoffer FA
- type
- Author
- name
- Grier HE
- type
- Author
- name
- Hawkins DS
- type
- Author
- name
- Raney RB
- type
- Author
- bibliography ids
- nci-bib-69dceddf5d3bb0017f301437
- book metadata
- content sha256
- 1e4b56e43d89d3a23349294caf2179cbf77ae687e25455c5b8a3cc1078a25cef
- document type
- citation
- dois
- 10.1002/pbc.24457
- electronic publication date
- display
- 2012 Dec 31
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23281268
- immutable id
- pubmed:23281268@1e4b56e43d89d3a23349294caf2179cbf77ae687e25455c5b8a3cc1078a25cef
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 7
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 1108-12
- volume
- 60
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23281268
- provenance
- batch id
- 99e85dbb34a1a3011c9a
- provider
- NCBI PubMed ESummary
- record sha256
- 0703f02fa5528b34708b7c8a293deff0818c1e4c65e0a4806545dcaace9d5516
- response sha256
- 1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
- retrieved at
- 2026-09-09T23:46:52.860383+00:00
- publication date
- display
- 2013 Jul
- precision
- month
- year
- 2013
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.
Preserved source evidence · Not medical advice